Given SCr measurements are low in neonates and hyperbilirubinemia is common, AKI may have been incorrectly estimated in the existing data and future research utilizing enzymatic methods for SCr measurement (which have been proven to be more accurate) or alternative markers (e.g., Cystatin C) should be considered [63,64]. This evidence concerns the gene CST3 and Hyperbilirubinemia.